Please assess the completion status of the following clinical trial:

Trial Title: D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Age \> 18 years~* After a first documented idiopathic proximal deep vein thrombosis and/or pulmonary embolism~* After at least 3 months of oral anticoagulation~* After written informed consent~Exclusion Criteria:~* If the Venous thromboembolism occurred:~* during pregnancy or puerperium~* after recent (i.e. within three months) fracture or plaster casting of a leg,~* after immobilization with confinement to bed for three consecutive days~* after surgery with general anesthesia lasting longer than 30 minutes~* Patients with:~* active cancer~* antiphospholipid antibody syndrome~* antithrombin deficiency~* serious liver disease or renal insufficiency (creatininemia \> 2 mg/dL),~* other indications for anticoagulation or contraindications for this treatment~* limited life expectation~* Patients who live too far from the clinical center

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).